Log in to save to my catalogue

Targeting mTOR for Anti-Aging and Anti-Cancer Therapy

Targeting mTOR for Anti-Aging and Anti-Cancer Therapy

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_1f664a8dbb9e4ecbad7d12a4522f9bb6

Targeting mTOR for Anti-Aging and Anti-Cancer Therapy

About this item

Full title

Targeting mTOR for Anti-Aging and Anti-Cancer Therapy

Author / Creator

Publisher

Switzerland: MDPI AG

Journal title

Molecules (Basel, Switzerland), 2023-04, Vol.28 (7), p.3157

Language

English

Formats

Publication information

Publisher

Switzerland: MDPI AG

More information

Scope and Contents

Contents

The balance between anabolism and catabolism is disrupted with aging, with the rate of anabolism being faster than that of catabolism. Therefore, mTOR, whose major function is to enhance anabolism and inhibit catabolism, has become a potential target of inhibition for anti-aging therapy. Interestingly, it was found that the downregulation of the mT...

Alternative Titles

Full title

Targeting mTOR for Anti-Aging and Anti-Cancer Therapy

Authors, Artists and Contributors

Author / Creator

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_1f664a8dbb9e4ecbad7d12a4522f9bb6

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_1f664a8dbb9e4ecbad7d12a4522f9bb6

Other Identifiers

ISSN

1420-3049

E-ISSN

1420-3049

DOI

10.3390/molecules28073157

How to access this item